跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9 条关于
“D4Z4”
全部
9
临床试验
5
药物
0
机构
0
资讯
4
去年
SOLVE FSHD Partners with Modalis to Develop CRISPR-Based Epigenome Editing Therapy for Muscular Dystrophy
去年
Epicrispr Biotechnologies Doses First Patient with EPI-321, Novel Epigenetic Therapy for Facioscapulohumeral Muscular Dystrophy
3个月前
Facioscapulohumeral Muscular Dystrophy Market Poised for Transformative Growth as Gene-Targeted Therapies Advance Toward Regulatory Submissions
3个月前
From Patient to Pioneer: How FSHD Researchers Are Redefining a Rare Disease Through Epigenetics and CRISPR